期刊文献+

基于小鼠MMP-9基因的siRNA的筛选

Construction and Screening of siRNA Recombinant Plasmids for Mouse MMP-9 Gene Silencing
原文传递
导出
摘要 通过GenBank数据库检索,基于小鼠MMP-9基因设计特异性的siRNA干扰靶点,克隆至pGCsi-U6/Neo/GFP载体中,使用PEI衍生物包裹,转染小鼠黑色素瘤B16细胞,流式细胞仪和激光扫描共聚焦显微镜分析细胞转染情况,RT-PCR检测24,48 h后MMP-9基因转录水平变化,筛选最佳的重组质粒和干扰靶点。结果显示:成功设计和构建了3个MMP-9-siRNA干扰质粒,3个重组质粒对B16细胞的转染率分别为60.04%、63.93%和56.27%,且3个重组质粒均能有效干扰B16细胞MMP-9 mRNA的表达,其中MMP-9-siRNA-2干扰效率最高(63%),可持续干扰MMP-9基因表达。这些结果提示,MMP-9-siRNA-2为沉默小鼠黑色素瘤细胞MMP-9基因最优的siRNA重组质粒。 Specific siRNA interference target sites were designed according to the sequence of mouse MMP-9 gene in GenBank,and oligonucleotides were synthesized and inserted into pGCsi-U6/Neo/GFP plasmid to constitute the recombinant plasmids,the siRNA recombinant plasmids were transfected into B16 cells by PEI derivative,which was confirmed by flow cytometry and laser scanning confocal microscope observation,and the interfering efficiency was evaluated by Real-time quantitative RT-PCR analysis.The results showed that three MMP-9-siRNA interference plasmids were designed and constructed successfully.Transfection efficiency of the three MMP-9-siRNA recombinant plasmids were 60.04%,63.93% and 56.27%,respectively,and the expression of MMP-9 mRNA in B16 cells was effectively down-regulated.The MMP-9-siRNA-2 had the highest interference efficiency(63%) and persistent interference.The results suggested that MMP-9-siRNA-2 is the optimal recombinant plasmid for?silencing MMP-9 gene of?mouse B16?cell.
出处 《中国细胞生物学学报》 CAS CSCD 北大核心 2012年第9期906-910,共5页 Chinese Journal of Cell Biology
基金 重庆市教委科学技术研究(No.KJ090302)资助项目~~
关键词 MMP-9 B16细胞 SIRNA RT-PCR MMP-9 B16 cell siRNA RT-PCR
  • 相关文献

参考文献13

  • 1Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, et al. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduc- estumor cell invasion, tumor growth and angiogenesis. Oncogene 2004; 23(27): 4681-9. 被引量:1
  • 2Kunigal S, Lakka SS, Gondi CS, Estes N, Ran JS. RNAi-mediat- ed downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int J Can- cer 2007; 121(10): 2307-16. 被引量:1
  • 3Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2(10): 737-44. 被引量:1
  • 4Hawinkels L J, Zuidwijk K, Verspaget HW, de Jonge-Muller ES, van Duijn W, Ferreira V, et al. VEGF release by MMP-9 medi- ated heparan sulphate cleavage induces colorectal cancer angio- genesis. Eur J Cancer 2008; 44(13): 1904-13. 被引量:1
  • 5Lipardi C, Wei Q, Paterson BM. RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are de- graded to generate new siRNAs. Cell 2001; 107(3): 297-307. 被引量:1
  • 6Arenz C, Schepers U. RNA interference: From an ancient mecha- nism to a state of the art therapeutic application? Naturwissen- schaften 2003; 90(8): 345-59. 被引量:1
  • 7Zamore PD, Tuschl T, Sharp PA, Bartel DP. RNAi: Double- stranded RNA directs the ATP dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000; 101(1): 25-33. 被引量:1
  • 8Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002; 26(2): 199-213. 被引量:1
  • 9Premsrirut PK, Dow LE, Kim SY, Camiolo M, Malone CD, Mi- ething C, et al. A Rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell 2011; 145(1): 145-58. 被引量:1
  • 10Lares MR, Rossi JJ, Ouellet DL. RNAi and small interfering RNAs in human disease therapeutic applications. Trends Bio- technol 2010; 28(11): 570-9. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部